Skip to content

Patient Concerns Inventory

Evaluation of Patient concerns using the Patients Concern Inventory (PCI) in Head Neck Radiation Oncology clinics: A longitudinal study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/090319
Enrollment
300
Registered
2025-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with histologically proven head and Neck Cancer 2. Patients treated with Curative Intent 3. Patients willing to sign the Informed Consent Form. 4. Literate Adult patients who are able to understand either English or Hindi will be included in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with synchronous or metachronous primaries or have received treatment for HN cancers in the past. 2. Illiterate Patients who do not understand the PCI themselves. 3. Patients who do not sign the consent form 4. Patients who exclusively speak Marathi or other regional language and are unable to understand either English or Hindi.

Design outcomes

Primary

MeasureTime frame
To address the enumerated Concerns of patients coming for Radiation Oncology consultation/ treatment with a curative intent in Head and Neck Cancers using the Patients Concern Inventory (at diagnosis) module.Timepoint: baseline, 3 months,6 months, 12 months

Secondary

MeasureTime frame
To address the enumerated concerns of patients post treatment in head neck cancer patients using the PCI-HN post treatment module for a total duration of 1 year post treatment.Timepoint: 3 months,6 months, 12 months

Countries

India

Contacts

Public ContactDr Sagar Suryawanshi

Tata memorial hospital

shwetabhsinha23@gmail.com02224177262

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026